The Role of Anti-mullerian Hormone (AMH) and AMHR2 Variants in Polycystic Ovary Syndrome: ‘A Comprehensive Analysis’
Authors' conclusion
Although AMH and AMHR2 variants may not directly influence PCOS susceptibility, they could play a role in modulating lipid metabolism associated with the syndrome.
Study context
- Population
- Tunisian women with polycystic ovary syndrome (PCOS) and healthy controls; genotyped for AMH (rs4807216, rs10407022, rs8,112,524) and AMHR2 (rs2002555, rs11170553, rs2,272,002) variants
- Participants
- 327 vs 396
- Comparison
- PCOS vs healthy controls
- PCOSn = 327
- Controlsn = 396reference
- Outcome
- Association of AMH and AMHR2 gene variants with PCOS risk and serum AMH levels
Methodological detailsGenotyping by TaqMan SNP genotyping assay; fasting serum AMH by ELISA
- Genotyping by TaqMan SNP genotyping assay; fasting serum AMH by ELISA
Main finding
As reported in the abstract
Association of AMH/AMHR2 variants with PCOS susceptibility
- No significant allelic, genotypic or haplotypic associations with PCOS
- No substantial impact of variants on serum AMH levels
- Interaction and epistasis analyses: no significant predictive capability of AMH and AMHR2 variants for PCOS susceptibility
Observational data: associations, not effects.
Further findings
Genotype–lipid profile correlations
- AMH rs8112524 A/A and G/A genotypes correlated with increased TG
- AMHR2 rs2002555 G/G and rs11170553 T/T and C/T genotypes correlated with decreased HDL
Clinical and metabolic differences, PCOS vs controls
- PCOS: higher BMI and elevated AMH, glucose, TG and cholesterol, with lower FSH
Original publication
The Role of AMH and AMHR2 Variants in Polycystic Ovary Syndrome: ‘A Comprehensive Analysis’. Clin Endocrinol (Oxf). Published 8 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →